在PD-1/PD-L1抑制剂免疫治疗后,非小细胞肺癌的超级进展性疾病:潜在的杀手性疾病
Yanping Li1, Tianhong Chen2, Tian Yi Nie1
1Department of Respiratory Medicine, The Third People's Hospital of Honghe Prefecture, Gejiu, China.
Frontiers in immunology
|June 7, 2023
概括
免疫检查点抑制剂 (ICI) 对非小细胞肺癌具有前景,但可以导致超前进性疾病 (HPD),一种侵袭性瘤生长. 这篇评论探讨了HPD的情况.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 医学研究 医学研究
背景情况:
- 免疫检查点抑制剂 (ICI) 通过阻断PD-1/PD-L1通路,利用T细胞对瘤的免疫功能.
- ICI已经改变了非小细胞肺癌 (NSCLC) 的免疫疗法.
- 然而,有一小部分患者经历过高进展性疾病 (HPD),其特征是瘤生长加速和预后不佳.
研究的目的:
- 在NSCLC的ICI治疗的背景下,提供超级进展性疾病 (HPD) 的全面概述.
- 阐明 HPD 的定义,潜在的生物标志物,潜在的机制和治疗策略.
- 为ICI治疗的好处和风险提供一个平衡的观点.
主要方法:
- 文献综述和现有关于ICI治疗和NSCLC中的HPD研究的综合.
- 分析与HPD相关的临床数据和临床前研究.
- 讨论建议的机制和治疗干预措施.
主要成果:
- 尽管其整体疗效,但HPD在NSCLC的ICI治疗中构成了重大挑战.
- 了解HPD的特征,生物标志物和机制对于患者管理至关重要.
- 目前HPD的治疗策略仍在调查中.
结论:
- ICI疗法为NSCLC患者提供了显著的益处,但也带有HPD的风险.
- 对HPD生物标志物和有效治疗方法的进一步研究对于优化免疫治疗结果至关重要.
- 对HPD的彻底理解对于平衡ICI的优缺点至关重要.
相关概念视频
02:07Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:27Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K